Physician profile
Jitendrakumar A Patel
NPI 1770785727
$846.73
in general payments reported to CMS, 2019-2025
15 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $29.15 · 2021: $65.89 · 2022: $75.13 · 2024: $299 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $102.09 | 2019-2025 | Eliquis |
| Janssen Scientific Affairs, LLC | $101.95 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $93.58 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.05 | 2024-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $79.70 | 2022-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $77.78 | 2020-2024 | Xarelto |
| Pfizer INC. | $61.78 | 2019 | |
| Paratek Pharmaceuticals, INC. | $46.44 | 2025 | Nuzyra |
| Solventum Corporation | $43.67 | 2025 | V.A.C.Ulta |
| Boston Scientific Corporation | $39.12 | 2025 | Watchman Access System |
| Abbvie INC. | $31.26 | 2021-2022 | |
| Viatris Specialty LLC | $30.58 | 2025 | Yupelri |
| Scpharmaceuticals INC. | $18.94 | 2024 | |
| Inari Medical, INC. | $16.29 | 2021 | |
| Allergan, INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jitendrakumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.